74 filings
8-K
MCET
MultiCell Technologies, Inc.
26 Sep 16
Other Events
12:00am
8-K
MCET
MultiCell Technologies, Inc.
13 Mar 15
Multicell Immunotherapeutics and Oxis Biotech Sign Antibody-drug Conjugate R&D, Product License and Commercialization Agreement
12:00am
8-K
MCET
MultiCell Technologies, Inc.
13 Mar 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
MCET
MultiCell Technologies, Inc.
28 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
MCET
MultiCell Technologies, Inc.
21 Nov 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
62a5g2vfue
3 Oct 13
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
12:00am
8-K
jo1 gne4up
12 Sep 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
mvogn6kt i01yklz2ek
14 Aug 13
Other Events
12:00am
8-K
gj2b78m79q ddh
6 Aug 13
MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
12:00am
8-K
8qvtbo9a4z g55
25 Oct 12
Entry into a Material Definitive Agreement
12:00am
8-K
1bwn0yua l0jwkai9ri7
24 Oct 12
Grant G. Miller Joins Board of MultiCell Technologies
12:00am
8-K
bz3wbsk
6 Sep 12
Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies
12:00am
8-K
14lozzl9ld
13 Aug 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7c3zti7nnwh8
6 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
8b8aihpnjas nabao
19 Aug 11
Entry into a Material Definitive Agreement
12:00am
8-K
cegvkx
13 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
rrjiiypes0
11 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
b3sqa
8 Nov 10
MultiCell Technologies Receives $733,437 Cash Grant Award Under U.S. Government's Qualifying Therapeutic Discovery Project Program
12:00am
8-K
9dp1p75dwyb9m9
20 Oct 10
Multicell’s Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
12:00am
8-K
pemz nr7w4f1
1 Sep 10
Submission of Matters to a Vote of Security Holders
12:00am